Two Popular Diabetes Drugs Outperformed Others in Massive Clinical Trial
Press release Wednesday, September 21, 2022 NIH-funded researchers complete first study comparing drugs commonly used for type 2 diabetes. In a large clinical trial directly comparing four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide were the best of the four drugs approved by the United States Food …
Two Popular Diabetes Drugs Outperformed Others in Massive Clinical Trial Read More »